Zambon Laboratorios Farmaceuticos Information

Zambon is a leading Italian family company that has operated for 109 years in the pharmaceutical industry in Europe and 57 years in Brazil. The Group operates directly in 73 countries with 15 operating subsidiaries in Europe, South America and Asia and counts with 6 production facilities (2 in Italy, Switzerland, France, Brazil and China). The company has 2,600 employees worldwide and 230 in Brazil. We primarily operate in three strategic areas: respiratory, pain and women’s health. In these sectors, the business covers the entire value chain. The Group is particularly focusing on strengthening the respiratory area with the treatment of severe diseases such as chronic obstructive pulmonary disease (COPD) and cystic fibrosis (CF), with the recent acquisition of Profile Pharma from Philips. We entered also into a new important therapeutic area, the Central Nervous System (CNS), with an innovative molecule for the treatment of Parkinson's disease. CNS and the Respiratory Business are the two main drivers of the company’s development strategy. Zambon is characterized by a strong identity, credibility and organizational values, which has their roots in the company foundation, by Gaetano Zambon, and is part of the organizational culture, being a company that effectively practices the care for people inside and outside the organization. One example of how we live our values is the “Benvivere” (wellbeing, in Italian), our work philosophy that sets how we take decisions, how we act and relate to each other in the daily work routine and also organizes our work life balance activities. These values and work principles are the bases to be one of the “130 Best Companies to Work For” in Brazil for the last 3 years, according to Você RH Magazine and Great Place to Work Institute.